US Stock MarketDetailed Quotes

SABS SAB Biotherapeutics

Watchlist

4.2900
-0.1700-3.81%

Close Apr 19 16:00 ET

4.2900
0.00000.00%

Post 16:00 ET

39.58MMarket Cap-561P/E (TTM)

SAB Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

-95.08%581.1K

11.8M

Operating revenue

--0

-95.08%581.1K

--0

--11.8M

Cost of revenue

Gross profit

Operating expense

31.67%38.08M

140.12%18.87M

-31.82%5.32M

-1.01%6.48M

10.36%7.4M

115.91%28.92M

7.02%7.86M

95.65%7.81M

127.78%6.54M

924.07%6.71M

Selling and administrative expenses

45.27%23.8M

416.22%14.88M

-36.44%2.57M

-32.70%2.9M

-33.53%3.45M

-4.11%16.38M

-62.82%2.88M

12.31%4.04M

79.65%4.31M

55.65%5.19M

-General and administrative expense

45.27%23.8M

416.22%14.88M

-36.44%2.57M

-32.70%2.9M

-33.53%3.45M

-4.11%16.38M

-62.82%2.88M

12.31%4.04M

79.65%4.31M

55.65%5.19M

Research and development costs

-54.68%16.52M

-39.80%4.3M

-45.33%4.02M

-57.34%3.66M

-65.96%4.54M

-36.28%36.44M

-32.96%7.14M

-51.21%7.35M

-54.05%8.58M

4.24%13.32M

Other operating expenses

90.63%-2.24M

85.88%-305.01K

64.69%-1.27M

98.65%-85.52K

95.08%-581.1K

60.73%-23.9M

80.46%-2.16M

75.55%-3.59M

65.13%-6.35M

30.27%-11.8M

Operating profit

-31.67%-38.08M

-140.12%-18.87M

31.82%-5.32M

1.01%-6.48M

-233.86%-6.82M

-115.91%-28.92M

-7.02%-7.86M

-95.65%-7.81M

-127.78%-6.54M

526.07%5.1M

Net non-operating interest income expense

216.99%269.68K

803.08%406.17K

-3.93%-55.34K

15.63%-46.75K

46.33%-34.4K

15.05%-230.51K

-0.07%-57.77K

28.81%-53.24K

19.85%-55.41K

8.03%-64.09K

Non-operating interest income

723.06%584.97K

1,517.31%484.05K

-17.38%14.36K

80.54%28.57K

630.97%57.99K

207.47%71.07K

250.29%29.93K

361.26%17.39K

198.79%15.82K

44.08%7.93K

Non-operating interest expense

4.54%315.28K

-11.20%77.88K

-1.31%69.7K

5.73%75.32K

28.27%92.39K

2.42%301.58K

32.33%87.7K

-10.10%70.63K

-4.30%71.24K

-4.22%72.02K

Other net income (expense)

-142.06%-4.39M

-6,478.39%-4.39M

-64.83%275.94K

-120.66%-357.52K

-98.95%82.59K

399.80%10.43M

101.66%68.81K

19,745.41%784.49K

1.73M

1,079.33%7.85M

Gain on sale of security

-146.38%-4.82M

-13,020.42%-4.73M

-77.17%178.76K

-120.66%-357.52K

-98.95%82.59K

350.52%10.4M

--36.59K

--782.96K

--1.73M

--7.85M

Other non- operating income (expenses)

1,189.00%435.09K

948.52%337.91K

6,264.31%97.18K

----

515.05%33.75K

1,999.48%32.23K

-61.37%1.53K

----

Income before tax

-125.45%-42.19M

-191.21%-22.86M

27.89%-5.1M

-41.34%-6.88M

-782.08%-7.35M

-9.16%-18.72M

32.05%-7.85M

-74.24%-7.08M

-65.49%-4.87M

-23.53%1.08M

Income tax

25.63K

-92.28K

92.28K

Net income

-125.14%-42.19M

-190.26%-22.86M

27.89%-5.1M

-44.07%-6.88M

-845.93%-7.35M

-9.31%-18.74M

31.83%-7.87M

-74.24%-7.08M

-62.36%-4.78M

-30.07%985.86K

Net income continuous Operations

-125.14%-42.19M

-190.26%-22.86M

27.89%-5.1M

-44.07%-6.88M

-845.93%-7.35M

-9.31%-18.74M

31.83%-7.87M

-74.24%-7.08M

-62.36%-4.78M

-30.07%985.86K

Minority interest income

Net income attributable to the parent company

-125.14%-42.19M

-190.26%-22.86M

27.89%-5.1M

-44.07%-6.88M

-845.93%-7.35M

-9.31%-18.74M

31.83%-7.87M

-74.24%-7.08M

-62.36%-4.78M

-30.07%985.86K

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-125.14%-42.19M

-190.26%-22.86M

27.89%-5.1M

-44.07%-6.88M

-845.93%-7.35M

-9.31%-18.74M

31.83%-7.87M

-74.24%-7.08M

-62.36%-4.78M

-30.07%985.86K

Basic earnings per share

-77.26%-7.64

-112.15%-3.84

37.50%-1

-27.27%-1.4

-850.00%-1.5

31.59%-4.31

31.86%-1.81

-71.28%-1.6

-62.57%-1.1

-38.33%0.2

Diluted earnings per share

-77.26%-7.64

-112.15%-3.84

37.50%-1

-27.27%-1.4

-850.00%-1.5

31.59%-4.31

31.86%-1.81

-71.28%-1.6

-62.57%-1.1

-38.33%0.2

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	0	0	0	0	-95.08%581.1K	0	0	0	0	11.8M
Operating revenue	--0	--0	--0	--0	-95.08%581.1K	--0	--0	--0	--0	--11.8M
Cost of revenue
Gross profit
Operating expense	31.67%38.08M	140.12%18.87M	-31.82%5.32M	-1.01%6.48M	10.36%7.4M	115.91%28.92M	7.02%7.86M	95.65%7.81M	127.78%6.54M	924.07%6.71M
Selling and administrative expenses	45.27%23.8M	416.22%14.88M	-36.44%2.57M	-32.70%2.9M	-33.53%3.45M	-4.11%16.38M	-62.82%2.88M	12.31%4.04M	79.65%4.31M	55.65%5.19M
-General and administrative expense	45.27%23.8M	416.22%14.88M	-36.44%2.57M	-32.70%2.9M	-33.53%3.45M	-4.11%16.38M	-62.82%2.88M	12.31%4.04M	79.65%4.31M	55.65%5.19M
Research and development costs	-54.68%16.52M	-39.80%4.3M	-45.33%4.02M	-57.34%3.66M	-65.96%4.54M	-36.28%36.44M	-32.96%7.14M	-51.21%7.35M	-54.05%8.58M	4.24%13.32M
Other operating expenses	90.63%-2.24M	85.88%-305.01K	64.69%-1.27M	98.65%-85.52K	95.08%-581.1K	60.73%-23.9M	80.46%-2.16M	75.55%-3.59M	65.13%-6.35M	30.27%-11.8M
Operating profit	-31.67%-38.08M	-140.12%-18.87M	31.82%-5.32M	1.01%-6.48M	-233.86%-6.82M	-115.91%-28.92M	-7.02%-7.86M	-95.65%-7.81M	-127.78%-6.54M	526.07%5.1M
Net non-operating interest income expense	216.99%269.68K	803.08%406.17K	-3.93%-55.34K	15.63%-46.75K	46.33%-34.4K	15.05%-230.51K	-0.07%-57.77K	28.81%-53.24K	19.85%-55.41K	8.03%-64.09K
Non-operating interest income	723.06%584.97K	1,517.31%484.05K	-17.38%14.36K	80.54%28.57K	630.97%57.99K	207.47%71.07K	250.29%29.93K	361.26%17.39K	198.79%15.82K	44.08%7.93K
Non-operating interest expense	4.54%315.28K	-11.20%77.88K	-1.31%69.7K	5.73%75.32K	28.27%92.39K	2.42%301.58K	32.33%87.7K	-10.10%70.63K	-4.30%71.24K	-4.22%72.02K
Other net income (expense)	-142.06%-4.39M	-6,478.39%-4.39M	-64.83%275.94K	-120.66%-357.52K	-98.95%82.59K	399.80%10.43M	101.66%68.81K	19,745.41%784.49K	1.73M	1,079.33%7.85M
Gain on sale of security	-146.38%-4.82M	-13,020.42%-4.73M	-77.17%178.76K	-120.66%-357.52K	-98.95%82.59K	350.52%10.4M	--36.59K	--782.96K	--1.73M	--7.85M
Other non- operating income (expenses)	1,189.00%435.09K	948.52%337.91K	6,264.31%97.18K	----	----	515.05%33.75K	1,999.48%32.23K	-61.37%1.53K	----	----
Income before tax	-125.45%-42.19M	-191.21%-22.86M	27.89%-5.1M	-41.34%-6.88M	-782.08%-7.35M	-9.16%-18.72M	32.05%-7.85M	-74.24%-7.08M	-65.49%-4.87M	-23.53%1.08M
Income tax	0			0	0	25.63K			-92.28K	92.28K
Net income	-125.14%-42.19M	-190.26%-22.86M	27.89%-5.1M	-44.07%-6.88M	-845.93%-7.35M	-9.31%-18.74M	31.83%-7.87M	-74.24%-7.08M	-62.36%-4.78M	-30.07%985.86K
Net income continuous Operations	-125.14%-42.19M	-190.26%-22.86M	27.89%-5.1M	-44.07%-6.88M	-845.93%-7.35M	-9.31%-18.74M	31.83%-7.87M	-74.24%-7.08M	-62.36%-4.78M	-30.07%985.86K
Minority interest income
Net income attributable to the parent company	-125.14%-42.19M	-190.26%-22.86M	27.89%-5.1M	-44.07%-6.88M	-845.93%-7.35M	-9.31%-18.74M	31.83%-7.87M	-74.24%-7.08M	-62.36%-4.78M	-30.07%985.86K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-125.14%-42.19M	-190.26%-22.86M	27.89%-5.1M	-44.07%-6.88M	-845.93%-7.35M	-9.31%-18.74M	31.83%-7.87M	-74.24%-7.08M	-62.36%-4.78M	-30.07%985.86K
Basic earnings per share	-77.26%-7.64	-112.15%-3.84	37.50%-1	-27.27%-1.4	-850.00%-1.5	31.59%-4.31	31.86%-1.81	-71.28%-1.6	-62.57%-1.1	-38.33%0.2
Diluted earnings per share	-77.26%-7.64	-112.15%-3.84	37.50%-1	-27.27%-1.4	-850.00%-1.5	31.59%-4.31	31.86%-1.81	-71.28%-1.6	-62.57%-1.1	-38.33%0.2
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall